#HealthCare #CommunityPartnerships #HealthLiteracy
www.newsweek.com
Health care leader to industry: Patients "don't care" about systemness
Large health systems across the United States are zeroing in on "systemness" as they attempt to compete with digital care providers that brand themselves as one-stop-shops.
#ChronicDisease #HealthcareInnovation #DigitalHealth
www.newsweek.com
Chronic pain patients find 'guardian angels' in health tech, experts say
More than three-quarters of Americans now live with at least one chronic condition, and over half live with multiple conditions -- but chronic pain patients are finding "guardian angels" thanks to new technologies, according to the health care experts who joined Newsweek's February 3 webinar, "Preventing Chronic Disease Patients from Falling Through the Cracks.
#womenshealth #healthcare #painmanagement
www.newsweek.com
Mom shares pain relief husband got for vasectomy, starts eye-opening debate
A woman from Ontario, Canada, has sparked a viral debate after comparing the pain management her husband received for his vasectomy with her own experience getting an IUD.
#HealthcareInnovation #ArtificialIntelligence #TechnologyAdoption
www.forbes.com
The AI Healthcare Chessboard: Why Entrepreneurs Should Bet On The Ecosystem, Not The Chatbot
In analyzing technology adoption across healthcare and enterprise systems, a single pattern emerges with undeniable clarity: platforms consistently outmuscle products.
#Healthcare #NursesStrike #Innovation
www.forbes.com
New York City Nurses And Hospitals Dig In During Strike's Second Week
In this week's edition of InnovationRx, we look at the New York city nurses' strike, why Yann LeCun's AI startup is focused on healthcare, Epic's new predictive tools, and more.
#Pharmaceuticals #DrugPricing #HealthcarePolicy
www.cnbc.com
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry
Big pharma is grappling with the impact of new drug pricing deals with President Donald Trump and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
